BOSTON, Nov. 7, 2019 /PRNewswire/ -- Seniorlink, Inc., a leading tech-enabled health services company, is pleased to announce an expanded relationship with leading health and well-being comp

MT. JACKSON, Va. and THURMONT, Md., Nov. 7, 2019 /PRNewswire/ -- StageBio has merged with Alizée Pathology to form the leading provider of specialized histology, pathology, biomarker development, and archiving services for the biopharmaceutical, medical device and contract research industries. StageBio was recently created by

HILLSBORO, Ore., Nov. 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific today announced the Thermo Scientific Aquilos 2 Cryo-FIB, a DualBeam system dedicated to the preparation of thin, electron-transparent samples from biological specimens. It simplifies the cryo-electron tomography (cryo-ET) workflow by reducing sample preparation time, minimizing the risk of conta

Tel Aviv, Israel, Nov. 7, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of innovative technology which enables the functional selection of stem cells, announced today that on November 6, 2019, it received notice from the Nasdaq Listing Center that Cellect successfully regained compliance with the minimum bi

CAMBRIDGE, England, Nov. 7, 2019 /PRNewswire/ -- FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck's portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-patented organic semiconductors and dielectrics. The deal makes FlexEnable the first company to offer displ

LA JOLLA, Calif., Nov. 7, 2019 /PRNewswire/ -- Kenneth Stauderman, Ph.D., CalciMedica's Chief Scientific Officer, is presenting a poster at the American Pancreas Association annual meeting November 7-10 in Wailea, Hawaii, entitled "Pharmacodynamic (PD)/Pharmacokinetic (PK) Study

BOTHELL, Wash., Nov. 7, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools fo

SAN DIEGO, Nov. 7, 2019 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has appointed Randall Kaye, M.D., as Chief Medical Officer (CMO). In this new role, Dr. Kaye will lead the clinical development of tolperisone, the company

BOCA RATON, Florida, Nov. 7, 2019 /PRNewswire/ -- Smart Decision, Inc. (OTC Pink Markets: SDEC), a next-generation consumer-based LED & CBD algorithm innovator, is pleased to announce that it has signed a Letter of Intent (LOI) with HempAmericana, Inc., a visionary in the CBD space.  "We're excited to have the opportunity to work with HempAmericana. Their

NEW YORK  and MIAMI, Nov. 7, 2019 /PRNewswire/ -- HealthCare.com, the fastest growing leader in technology-enabled health insurance solutions, today announced that it ha